Staar Surgical Co.
STAA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.08B
Close$
$2.18
90.2% downside
Current Fair Value
90.2% downsideOvervalued by 90.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.08 Billion |
|---|---|
| Enterprise Value | $966.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.62 |
| Beta | 1.18 |
| Outstanding Shares | 50,321,000 |
Return
| Return on Equity | -2166.06% |
|---|---|
| Return on Assets | -1665.54% |
| Return on Invested Capital | 7.07% |
Valuation & Multiples
| P/E Ratio | 270.88 |
|---|---|
| PEG | -183.11 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 3.18 |
| Enterprise Value to Revenue | 0.01 |
| Enterprise Value to EBIT | 33.99 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$0.22
Average shareholder expectationRevenue Estimate
$90.60 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
$78.73 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 90.53% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.45%▼ 108.07% |
|---|---|
| Total Invested | $39.28M▼ 97.54% |
| Investors Holding | 8▼ 203.00% |
ESG Score
No data
About Staar Surgical Co.
CEO: Caren Mason